Overview

Glucose-dependent Insulinotropic Polypeptide - New Role as Blood Glucose Stabilizer?

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether glucose-dependent insulinotropic polypeptide (GIP) has a stabilizing function on the blood glucose
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University Hospital, Gentofte, Copenhagen
Treatments:
Gastric Inhibitory Polypeptide